COVID-19 Response: Local Logistics     National Effort

CCAMP signed MoU with Trivitron to commercialise a microfluidics analyser for POC diagnostics

You are here

COVID-19 Response: Local Logistics     National Effort

CCAMP and Trivitron Healthcare India have signed MoU to codevelop & commercialise completely indigenous technologies for advanced & affordable point-of-care diagnostics applications. 

The Mou was signed by CCAMP CEO & Director, Dr Taslimarif Saiyed and Dr. GSK Velu, Trivitron Healthcare Chairman and MD, in presence of Dr Renu Swarup, DBT Secretary and Dr Manish Diwan, Head, SPED, BIRAC.

CCAMP in partnership with IIT Madras has developed a first-of-its-kind multiplex microfluidics fluorescent analyser that is being licensed out to Trivitron. CCAMP's translational science program the Discovery to Innovation Accelerator or DIA has been instrumental in the development of this multi-geography patented technology. 

We look forward to a fruitful partnership with Trivitron and many more such examples of translation of bench level science to a product with social and commercial impact. 

Press coverage: 

  1.  https://timesofindia.indiatimes.com/business/india-business/trivitron-c-camp-ink-pact-to-co-develop-healthcare-technologies/articleshow/70485401.cms
  2. https://www.thehindubusinessline.com/companies/trivitron-healthcare-ties-up-with-c-camp-for-co-development-of-healthcare-technology/article28782003.ece
  3. https://www.biospectrumindia.com/news/74/14355/trivitron-inks-strategic-alliance-with-c-camp.html
  4. https://www.medicalbuyer.co.in/trivitron-inks-a-strategic-alliance-with-c-camp-an-initiative-with-department-of-biotechnology-government-of-india/

           

 

Date: 
August 2, 2019